MRI Radiomic Signature of White Matter Hyperintensities Is Associated With Clinical Phenotypes
Bonkhoff, Anna K
Schirmer, Markus D
Dalca, Adrian V
Donahue, Kathleen L
Etherton, Mark R
Rist, Pamela M
Regenhardt, Robert W
Benavente, Oscar R
Cole, John W
Griessenauer, Christoph J
Kittner, Steven J
Levi, Christopher R
McArdle, Patrick F
McDonough, Caitrin W
Meschia, James F
Sacco, Ralph L
Stanne, Tara M
Worrall, Bradford B
Maguire, Jane M
Rost, Natalia S
JournalFrontiers in Neuroscience
PublisherFrontiers Media S.A.
MetadataShow full item record
AbstractObjective: Neuroimaging measurements of brain structural integrity are thought to be surrogates for brain health, but precise assessments require dedicated advanced image acquisitions. By means of quantitatively describing conventional images, radiomic analyses hold potential for evaluating brain health. We sought to: (1) evaluate radiomics to assess brain structural integrity by predicting white matter hyperintensities burdens (WMH) and (2) uncover associations between predictive radiomic features and clinical phenotypes. Methods: We analyzed a multi-site cohort of 4,163 acute ischemic strokes (AIS) patients with T2-FLAIR MR images with total brain and WMH segmentations. Radiomic features were extracted from normal-appearing brain tissue (brain mask–WMH mask). Radiomics-based prediction of personalized WMH burden was done using ElasticNet linear regression. We built a radiomic signature of WMH with stable selected features predictive of WMH burden and then related this signature to clinical variables using canonical correlation analysis (CCA). Results: Radiomic features were predictive of WMH burden (R2 = 0.855 ± 0.011). Seven pairs of canonical variates (CV) significantly correlated the radiomics signature of WMH and clinical traits with respective canonical correlations of 0.81, 0.65, 0.42, 0.24, 0.20, 0.15, and 0.15 (FDR-corrected p-valuesCV1–6 < 0.001, p-valueCV7 = 0.012). The clinical CV1 was mainly influenced by age, CV2 by sex, CV3 by history of smoking and diabetes, CV4 by hypertension, CV5 by atrial fibrillation (AF) and diabetes, CV6 by coronary artery disease (CAD), and CV7 by CAD and diabetes. Conclusion: Radiomics extracted from T2-FLAIR images of AIS patients capture microstructural damage of the cerebral parenchyma and correlate with clinical phenotypes, suggesting different radiographical textural abnormalities per cardiovascular risk profile. Further research could evaluate radiomics to predict the progression of WMH and for the follow-up of stroke patients’ brain health.
Rights/TermsCopyright © 2021 Bretzner, Bonkhoff, Schirmer, Hong, Dalca, Donahue, Giese, Etherton, Rist, Nardin, Marinescu, Wang, Regenhardt, Leclerc, Lopes, Benavente, Cole, Donatti, Griessenauer, Heitsch, Holmegaard, Jood, Jimenez-Conde, Kittner, Lemmens, Levi, McArdle, McDonough, Meschia, Phuah, Rolfs, Ropele, Rosand, Roquer, Rundek, Sacco, Schmidt, Sharma, Slowik, Sousa, Stanne, Strbian, Tatlisumak, Thijs, Vagal, Wasselius, Woo, Wu, Zand, Worrall, Maguire, Lindgren, Jern, Golland, Kuchcinski and Rost.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/16296
- Predicting the Development of Normal-Appearing White Matter With Radiomics in the Aging Brain: A Longitudinal Clinical Study.
- Authors: Shao Y, Chen Z, Ming S, Ye Q, Shu Z, Gong C, Pang P, Gong X
- Issue date: 2018
- Radiomics from magnetic resonance imaging may be used to predict the progression of white matter hyperintensities and identify associated risk factors.
- Authors: Shu Z, Xu Y, Shao Y, Pang P, Gong X
- Issue date: 2020 Jun
- Comparing the Performance of Two Radiomic Models to Predict Progression and Progression Speed of White Matter Hyperintensities.
- Authors: Shao Y, Ruan J, Xu Y, Shu Z, He X
- Issue date: 2021
- Metric to quantify white matter damage on brain magnetic resonance images.
- Authors: Valdés Hernández MDC, Chappell FM, Muñoz Maniega S, Dickie DA, Royle NA, Morris Z, Anblagan D, Sakka E, Armitage PA, Bastin ME, Deary IJ, Wardlaw JM
- Issue date: 2017 Oct
- A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
- Authors: Sun R, Limkin EJ, Vakalopoulou M, Dercle L, Champiat S, Han SR, Verlingue L, Brandao D, Lancia A, Ammari S, Hollebecque A, Scoazec JY, Marabelle A, Massard C, Soria JC, Robert C, Paragios N, Deutsch E, Ferté C
- Issue date: 2018 Sep